Portland-based TomegaVax Inc., a spinoff from Oregon Health and Science University that’s working on an HIV vaccine, was recently acquired by San Francisco-based Vir Biotechnology.
Portland Business Journal reported on the development earlier in January 2017.
You can read their full report online.
(Editor’s note: One of SIP’s bloggers is now affiliated with OHSU but is not involved with any of these companies nor OHSU’s communications department. Also, the pace of posting on SIP may slow for a while, as work and other life demands have increased for both of its volunteer bloggers.)